Clinical Trial: CP101 for the Treatment of Ulcerative Colitis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ulcerative Colitis
Study Type: INTERVENTIONAL
Official Title: CP101 for the Treatment of Ulcerative Colitis
Brief Summary:
This is a dose ranging exploratory phase 1 pilot study to assess engraftment, safety, and efficacy of CP101, an oral microbiome therapeutic, in participants with active mild-to-moderate Ulcerative colitis.A total of 30 patients who meet eligibility criteria will be randomized 1:1 to either a short or extended induction dosing with CP101.An assessment of the microbiome will occur at baseline, Day 6, Week 4, Week 8, Week 12, Week 16, and Week 24.
Read more